Hygieia
Diabetes management company Hygieia extended its Series B round, and Autonomize AI, a workflow platform for healthcare and life sciences, also announced funding.
The d-Nav Insulin Guidance Service was also the focus of a multi-center, randomized control trial published last week in the Lancet.
This weekend saw the kickoff of the American Diabetes Association’s 78th annual conference, and with it a slew of new data from diabetes management players.